Equity

Hot Pursuit

Alembic Pharma rises after receiving USFDA approval for Dapsone Gel, 5%
(29-Jun-2026, 09:58 Hours IST)  
The approved ANDA is therapeutically equivalent to Aczone Gel, 5%, of Almirall, LLC, and is indicated for the topical treatment of acne vulgaris. With this approval, Alembic Pharmaceuticals now has a cumulative total of 244 ANDA approvals from the USFDA, comprising 224 final approvals and 20 tentative approvals.

Alembic Pharmaceuticals is a vertically integrated research and development pharmaceutical company. It manufactures and markets generic pharmaceutical products all over the world. Its research and manufacturing facilities are approved by regulatory authorities of many developed countries, including the USFDA.

The company's consolidated net profit jumped 29.19% to Rs 202.70 crore in Q4 FY26, compared to Rs 156.89 crore posted in Q4 FY25. Revenue from operations grew 4.41% year on year (YoY) to Rs 1,847.72 crore in the quarter ended 31 March 2026.

Powered by Capital Market - Live News

Monday, June 29, 2026 12:20:00 PM
Adani Ports1784.20comprofit(-0.67)%
      
Asian Paints2644.45comprofit(-0.05)%
      
Axis Bank1373.70comprofit(-0.21)%
      
Bajaj Finance981.60comprofit(0.17)%
      
Bajaj Finserv1767.20comprofit(0.17)%
      
Bharat Electro..405.80comprofit(-0.25)%
      
Bharti Airtel1838.30comprofit(-0.64)%
      
Eternal258.20comprofit(1.16)%
      
HCL Technologi..1096.85comprofit(-0.42)%
      
HDFC Bank798.65comprofit(0.33)%
      
Hind. Unilever2168.35comprofit(-0.23)%
      
ICICI Bank1385.80comprofit(-0.15)%
      
Infosys1031.50comprofit(-0.95)%
      
Interglobe Avi..5326.60comprofit(-2.26)%
      
ITC290.35comprofit(0.10)%
      
Kotak Mah. Ban..398.25comprofit(-2.63)%
      
Larsen & Toubr..4190.10comprofit(-0.71)%
      
M & M3108.05comprofit(-2.32)%
      
Maruti Suzuki13562.15comprofit(-1.31)%
      
NTPC356.50comprofit(1.24)%
      
Power Grid Cor..287.00comprofit(1.07)%
      
Reliance Indus..1303.10comprofit(-1.15)%
      
SBI1033.40comprofit(-1.12)%
      
Sun Pharma.Ind..1883.20comprofit(1.13)%
      
Tata Steel191.25comprofit(1.35)%
      
TCS2080.00comprofit(-0.74)%
      
Tech Mahindra1443.50comprofit(0.48)%
      
Titan Company4272.80comprofit(-0.39)%
      
Trent3275.45comprofit(1.81)%
      
UltraTech Cem.11400.00comprofit(-0.81)%
      

FOR GRIEVANCE MAIL TO invgrieviss@iseindia.com

BSE EQUITIES : INB011077733 | NSE F&O EQUITIES : INF231077737 | NSE CASH MARKET : INB231077737 | NSE CURRENCY DERIVATIVES : INE231077737 | MCX-SX : INE261077737

ISS Enterprise Limited [Erstwhile: ISE Securities & Services Limited], a wholly owned subsidiary of Inter-connected Stock Exchange of India Ltd. (ISE)

© 2013 ISS Enterprise Limited [Erstwhile: ISE Securities & Services Limited]. All rights reserved.

Designed, developed & powered by C-MOTS Infotech (ISO 9001:2008 certified)